| Year |
Citation |
Score |
| 2019 |
Farrell M, Lichtenstein M, Crowley J, Filmyer D, Lázaro-Muñoz G, Shaughnessy R, Mackenzie IR, Hirsch-Reinshagen V, Stowe R, Evans J, Berg J, Szatkiewicz J, Josiassen R, Sullivan PF. THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1006-S1007. DOI: 10.1016/J.Euroneuro.2017.08.401 |
0.353 |
|
| 2017 |
Josiassen RC, Filmyer DM, Gillean J, Shah SS, Dietterich TE, Shaughnessy RA. Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient's Perspective. The American Journal of Case Reports. 18: 1185-1189. PMID 29114100 DOI: 10.12659/Ajcr.906454 |
0.301 |
|
| 2017 |
Kane J, Josiassen R, Burke J, Jimenez R, Siegert S, Liang G. SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia Schizophrenia Bulletin. 43: S119-S119. DOI: 10.1093/Schbul/Sbx023.016 |
0.348 |
|
| 2012 |
Geboy AG, Filmyer DM, Josiassen RC. Motor deficits associated with mild, chronic hyponatremia: a factor analytic study. Journal of Motor Behavior. 44: 255-9. PMID 22671716 DOI: 10.1080/00222895.2012.688895 |
0.33 |
|
| 2012 |
Josiassen RC, Curtis JL, Shaughnessy RA, Filmyer DM, Geboy AG, Skuban N, Ouyang J, Czerwiec F. Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients. Clinical Schizophrenia & Related Psychoses. 6: 21-6. PMID 22453866 DOI: 10.3371/Csrp.6.1.3 |
0.333 |
|
| 2012 |
Josiassen RC, Filmyer DM, Geboy AG, Martin DM, Curtis JL, Shaughnessy RA, Salzman A, Orlandi C. Psychomotor deficits associated with hyponatremia: a retrospective analysis. The Clinical Neuropsychologist. 26: 74-87. PMID 22087848 DOI: 10.1080/13854046.2011.628697 |
0.336 |
|
| 2010 |
Josiassen RC, Shaughnessy RA, Filymer DM, Donohue AM, Kacso M, Finkel N, Curtis J, Audino B, Skuban N. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study. Early Intervention in Psychiatry. 4: 57-63. PMID 20199481 DOI: 10.1111/J.1751-7893.2010.00163.X |
0.349 |
|
| 2010 |
Josiassen RC, Curtis J, Filmyer DM, Audino B, Skuban N, Shaughnessy RA. Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders. Expert Opinion On Pharmacotherapy. 11: 637-48. PMID 20163274 DOI: 10.1517/14656561003610656 |
0.331 |
|
| 2009 |
Josiassen RC, Filmyer DM, Curtis JL, Shaughnessy RA, Joseph A, Parson RL, Kacso M, Fedde J, Cornelius MD, Joseph M, Weinstein J, Skuban N, Victor T. An archival, follow-forward exploration of the metabolic syndrome in randomly selected, clozapine-treated patients Clinical Schizophrenia and Related Psychoses. 3: 87-96. DOI: 10.3371/Csrp.3.2.3 |
0.326 |
|
| 2008 |
Josiassen RC, Goldman M, Jessani M, Shaughnessy RA, Albazzaz A, Lee J, Ouyang J, Orlandi C, Czerwiec F. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biological Psychiatry. 64: 1097-100. PMID 18692175 DOI: 10.1016/J.Biopsych.2008.06.017 |
0.369 |
|
| 2008 |
Josiassen R, Skuban N, Kacso M, Filmyer D, Davis M, Shaughnessy R, Curtis J, Cornelius M. EARLY EFFECTS OF CLOZAPINE TREATMENT ON THE GLUCOSE-INSULINHOMEOSTASIS IN PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 102: 237-238. DOI: 10.1016/S0920-9964(08)70716-3 |
0.313 |
|
| 2006 |
Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology. 188: 281-92. PMID 16953381 DOI: 10.1007/S00213-006-0541-X |
0.365 |
|
| 2005 |
Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. The American Journal of Psychiatry. 162: 130-6. PMID 15625211 DOI: 10.1176/Appi.Ajp.162.1.130 |
0.348 |
|
| 2005 |
Citrome L, Josiassen R, Bark N, Salazar DE, Mallikaarjun S. Pharmacokinetics of aripiprazole and concomitant lithium and valproate. Journal of Clinical Pharmacology. 45: 89-93. PMID 15601809 DOI: 10.1177/0091270004269870 |
0.318 |
|
| 2004 |
Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, Josiassen RC. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. The Journal of Clinical Psychiatry. 65: 1491-8. PMID 15554761 DOI: 10.4088/Jcp.V65N1108 |
0.361 |
|
| 2003 |
de Leon J, Odom-White A, Josiassen RC, Diaz FJ, Cooper TB, Simpson GM. Serum antimuscarinic activity during clozapine treatment. Journal of Clinical Psychopharmacology. 23: 336-41. PMID 12920408 DOI: 10.1097/01.Jcp.0000085405.08426.73 |
0.301 |
|
| 2001 |
Tracy JI, Monaco C, Giovannetti T, Abraham G, Josiassen RC. Anticholinergicity and cognitive processing in chronic schizophrenia. Biological Psychology. 56: 1-22. PMID 11240312 DOI: 10.1016/S0301-0511(00)00083-1 |
0.344 |
|
| 1999 |
Nair CJ, Josiassen RC, Abraham G, Stanilla JK, Tracy JI, Simpson GM. Does akathisia influence psychopathology in psychotic patients treated with clozapine? Biological Psychiatry. 45: 1376-83. PMID 10349044 DOI: 10.1016/S0006-3223(98)00146-2 |
0.33 |
|
| 1998 |
Tracy JI, Monaco CA, Abraham G, Josiassen RC, Pollock BG. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone. The Journal of Clinical Psychiatry. 59: 184-8. PMID 9590669 DOI: 10.4088/Jcp.V59N0407 |
0.363 |
|
| 1997 |
Abraham G, Nair C, Tracy JI, Simpson GM, Josiassen RC. The effects of clozapine on symptom clusters in treatment-refractory patients. Journal of Clinical Psychopharmacology. 17: 49-53. PMID 9004057 DOI: 10.1097/00004714-199702000-00009 |
0.358 |
|
| 1997 |
Abraham G, Tracy JI, Stanilla JK, Verghese C, Simpson GM, Josiassen RC. The relationship of extrapyramidal symptoms and schizophrenia psychopathology Schizophrenia Research. 24: 263. DOI: 10.1016/S0920-9964(97)82755-7 |
0.382 |
|
| 1996 |
Tracy JI, De Leon J, Doonan R, Musciente J, Ballas T, Josiassen RC. Clock drawing in schizophrenia. Psychological Reports. 79: 923-8. PMID 8969101 DOI: 10.2466/Pr0.1996.79.3.923 |
0.355 |
|
| 1996 |
Tracy JI, McGrory AC, Josiassen RC, Monaco CA. A comparison of reading and demographic-based estimates of premorbid intelligence in schizophrenia. Schizophrenia Research. 22: 103-9. PMID 8958593 DOI: 10.1016/S0920-9964(96)00058-8 |
0.357 |
|
| 1996 |
Verghese C, de Leon J, Josiassen RC. Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophrenia Bulletin. 22: 455-64. PMID 8873296 DOI: 10.1093/Schbul/22.3.455 |
0.317 |
|
| 1996 |
Josiassen RC, Schindler B. Medical comorbidity and schizophrenia: editors' introduction. Schizophrenia Bulletin. 22: 411-2. PMID 8873292 DOI: 10.1093/Schbul/22.3.411 |
0.323 |
|
| 1996 |
Guterman Y, Josiassen RC, Bashore TE, Johnson M, Lubow RE. Latent inhibition effects reflected in event-related brain potentials in healthy controls and schizophrenics. Schizophrenia Research. 20: 315-26. PMID 8827859 DOI: 10.1016/0920-9964(95)00086-0 |
0.376 |
|
| 1996 |
Nair C, Abraham G, Leon Jd, Stanilla JK, Josiassen RC, Simpson G. Dose-related effects of clozapine on tardive dyskinesia among “treatment-refractory” patients with schizophrenia Biological Psychiatry. 39: 529-530. DOI: 10.1016/0006-3223(96)84052-2 |
0.328 |
|
| 1995 |
Tracy JI, Oesterling R, Josiassen RC. Transient fluctuations in cognitive functioning in schizophrenia based on single-case study methods. Schizophrenia Research. 17: 201-9. PMID 8562495 DOI: 10.1016/0920-9964(94)00086-N |
0.324 |
|
| 1995 |
Tracy JI, McGrory AE, Josiassen RC. Selective attention asymmetries in schizophrenia Schizophrenia Research. 15: 137. DOI: 10.1016/0920-9964(95)95425-9 |
0.301 |
|
| 1995 |
Tracy JI, Josiassen RC, Bellack AS. Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders Clinical Psychology Review. 15: 67-97. DOI: 10.1016/0272-7358(95)00001-6 |
0.329 |
|
| 1994 |
de Leon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biological Psychiatry. 35: 408-19. PMID 8018788 DOI: 10.1016/0006-3223(94)90008-6 |
0.301 |
|
| 1994 |
Guterman Y, Josiassen RC. Sensory gating deviance in schizophrenia in the context of task related effects. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 18: 1-12. PMID 7876034 DOI: 10.1016/0167-8760(84)90010-2 |
0.374 |
|
| 1994 |
Tracy J, Eby L, de Leon J, Doonan R, Ballas T, Josiassen R. The stability and agreement of general impairment indicators in schizophrenia Biological Psychiatry. 35: 637. DOI: 10.1016/0006-3223(94)90739-0 |
0.31 |
|
| 1994 |
Cloud BS, White AO, Tracy J, Oesterling R, Leon Jd, Josiassen R, Simpson G. The effects of chronic psychosis on rivermead behavioral memory test performance Biological Psychiatry. 35: 637. DOI: 10.1016/0006-3223(94)90738-2 |
0.334 |
|
| 1992 |
Guterman Y, Josiassen RC, Bashore TR. Attentional influence on the P50 component of the auditory event-related brain potential. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 12: 197-209. PMID 1592673 DOI: 10.1016/0167-8760(92)90011-Y |
0.345 |
|
| 1990 |
Josiassen RC, Roemer RA, Johnson MM, Shagass C. Are gender differences in schizophrenia reflected in brain event-related potentials? Schizophrenia Bulletin. 16: 229-46. PMID 2374882 DOI: 10.1093/Schbul/16.2.229 |
0.754 |
|
| 1990 |
Roemer RA, Josiassen RC, Shagass C. Comparing principal components analyses of evoked potentials recorded from heterogeneous groups of subjects. Psychophysiology. 27: 101-10. PMID 2339183 DOI: 10.1111/J.1469-8986.1990.Tb02187.X |
0.71 |
|
| 1990 |
Josiassen RC, Shagass C, Roemer RA, Slepner S, Czartorysky B. Early cognitive components of somatosensory event-related potentials. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 9: 139-49. PMID 2228748 DOI: 10.1016/0167-8760(90)90068-O |
0.723 |
|
| 1988 |
Josiassen RC, Shagass C, Roemer RA. Somatosensory evoked potential correlates of schizophrenic subtypes identified by the Millon Clinical Multiaxial Inventory. Psychiatry Research. 23: 209-19. PMID 3363029 DOI: 10.1016/0165-1781(88)90011-X |
0.714 |
|
| 1988 |
Josiassen RC, Shagass C, Roemer RA. Dealing with differential gender and age effects in evoked potential studies of psychopathology. Biological Psychiatry. 23: 612-27. PMID 3355878 DOI: 10.1016/0006-3223(88)90008-X |
0.702 |
|
| 1988 |
Josiassen RC, Shagass C, Roemer RA, Slepner S. Evoked potential correlates of intelligence in nonpatient subjects. Biological Psychology. 27: 207-25. PMID 3254727 DOI: 10.1016/0301-0511(88)90031-2 |
0.73 |
|
| 1988 |
Josiassen RC, Johnson MM. Age, gender and ERPs in schizophrenia. Let's at least handle the easy ones. Schizophrenia Research. 1: 365-7. PMID 3154524 DOI: 10.1016/0920-9964(88)90051-5 |
0.326 |
|
| 1988 |
Josiassen RC, Shagass C, Roemer RA, Mancall E. A sensory evoked potential comparison of persons 'at risk' for Huntington's disease and hospitalized neurotic patients. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 6: 281-9. PMID 2976064 DOI: 10.1016/0167-8760(88)90015-3 |
0.735 |
|
| 1988 |
Shagass C, Roemer RA, Josiassen RC. Some quantitative EEG findings in unmedicated and medicated major depressives. Neuropsychobiology. 19: 169-75. PMID 2907777 DOI: 10.1159/000118455 |
0.706 |
|
| 1988 |
Galzigna L, Fasolato C, Bianchi M, Burlina AP, Preview A, Jacqmin P, Ansseau M, Shagass C, Roemer RA, Josiassen RC, Vieweg WVR, Godleski LS, Pavalonis DL, Hundley PL, Yank GR, et al. Subject Index Vol. 19, 1988 Neuropsychobiology. 19: 218-219. DOI: 10.1159/000118464 |
0.596 |
|
| 1988 |
Galzigna L, Fasolato C, Bianchi M, Burlina AP, Preview A, Jacqmin P, Ansseau M, Shagass C, Roemer RA, Josiassen RC, Vieweg WVR, Godleski LS, Pavalonis DL, Hundley PL, Yank GR, et al. Contents, Vol. 19, 1988 Neuropsychobiology. 19. DOI: 10.1159/000118454 |
0.539 |
|
| 1988 |
Shagass C, Josiassen RC, Roemer RA. Psychiatric diagnostic differentiations by evoked potential measures: Results of a second series Research Communications in Psychology, Psychiatry and Behavior. 13: 43-75. |
0.69 |
|
| 1986 |
Josiassen RC, Curry LM, Mancall EL, Shagass C, Roemer RA. Relationship between evoked potential and neuropsychological findings in persons "at risk" for Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 8: 21-36. PMID 2935556 DOI: 10.1080/01688638608401294 |
0.716 |
|
| 1985 |
Josiassen RC, Shagass C, Roemer RA, Straumanis JJ. Attention-related effects on somatosensory evoked potentials in college students at high risk for psychopathology. Journal of Abnormal Psychology. 94: 507-18. PMID 4078154 DOI: 10.1037//0021-843X.94.4.507 |
0.761 |
|
| 1985 |
Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Combinations of evoked potential amplitude measurements in relation to psychiatric diagnosis. Biological Psychiatry. 20: 701-22. PMID 4005332 DOI: 10.1016/0006-3223(85)90150-7 |
0.734 |
|
| 1984 |
Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Psychiatric diagnostic discriminations with combinations of quantitative EEG variables. The British Journal of Psychiatry : the Journal of Mental Science. 144: 581-92. PMID 6743925 DOI: 10.1192/Bjp.144.6.581 |
0.715 |
|
| 1984 |
Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Distinctive somatosensory evoked potential features in obsessive-compulsive disorder. Biological Psychiatry. 19: 1507-24. PMID 6518205 |
0.733 |
|
| 1984 |
Josiassen RC, Shagass C, Mancall EL, Roemer RA. Auditory and visual evoked potentials in Huntington's disease. Electroencephalography and Clinical Neurophysiology. 57: 113-8. PMID 6198151 DOI: 10.1016/0013-4694(84)90169-X |
0.745 |
|
| 1984 |
Josiassen RC, Shagass C, Straumanis JJ, Roemer RA. Psychiatric drugs and the somatosensory P400 wave. Psychiatry Research. 11: 151-62. PMID 6143336 DOI: 10.1016/0165-1781(84)90099-4 |
0.738 |
|
| 1983 |
Shagass C, Josiassen RC, Roemer RA, Straumanis JJ, Slepner SM. Failure to replicate evoked potential observations suggesting corpus callosum dysfunction in schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 142: 471-6. PMID 6871561 DOI: 10.1192/Bjp.142.5.471 |
0.72 |
|
| 1983 |
Roemer RA, Shagass C, Josiassen RC, Straumanis JJ, Slepner SM. Rheoencephalographic concomitants of cognitive engagement in nonpatients and schizophrenics. An exploratory study. Human Neurobiology. 2: 97-102. PMID 6629879 |
0.668 |
|
| 1983 |
Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Archives of Neurology. 40: 791-6. PMID 6227312 DOI: 10.1001/Archneur.1983.04050120041005 |
0.321 |
|
| 1982 |
Josiassen RC, Shagass C, Roemer RA, Ercegovac DV, Straumanis JJ. Somatosensory evoked potential changes with a selective attention task. Psychophysiology. 19: 146-59. PMID 7071293 DOI: 10.1111/J.1469-8986.1982.Tb02536.X |
0.686 |
|
| 1982 |
Josiassen RC, Curry L, Roemer RA, DeBease C, Mancall EL. Patterns of intellectual deficit in Huntington's disease. Journal of Clinical Neuropsychology. 4: 173-83. PMID 6213679 DOI: 10.1080/01688638208401127 |
0.589 |
|
| 1982 |
Josiassen RC, Shagass C, Mancall EL, Roemer RA. Somatosensory evoked potentials in Huntington's disease. Electroencephalography and Clinical Neurophysiology. 54: 483-93. PMID 6181971 DOI: 10.1016/0013-4694(82)90033-5 |
0.748 |
|
| 1981 |
Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Intelligence as a factor in evoked potential studies of psychopathology. I. Comparison of low and high IQ subjects. Biological Psychiatry. 16: 1007-30. PMID 7349616 |
0.735 |
|
| 1981 |
Josiassen RC, Shagass C, Roemer RA, Straumanis JJ. The attention-related somatosensory evoked potential late positive wave in psychiatric patients. Psychiatry Research. 5: 147-55. PMID 6945610 DOI: 10.1016/0165-1781(81)90045-7 |
0.742 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2004 |
de Leon J, Diaz FJ, Wedlund P, Josiassen RC, Cooper TB, Simpson GM. Haloperidol half-life after chronic dosing. Journal of Clinical Psychopharmacology. 24: 656-60. PMID 15538130 DOI: 10.1097/01.Jcp.0000145340.53417.Ca |
0.299 |
|
| 2000 |
Tracy JI, Monaco C, Giovannetti T, Abraham G, Josiassen RC. The effects of 'acute' cigarette smoking on cognitive functioning in chronic schizophrenia Cognitive Neuropsychiatry. 5: 193-217. DOI: 10.1080/13546800050083539 |
0.299 |
|
| 1998 |
Nair CJ, Abraham G, Stanilla JK, Tracy JI, De Leon J, Simpson GM, Josiassen RC. Therapeutic effects of clozapine on tardive dyskinesia Cognitive and Behavioral Practice. 5: 123-131. DOI: 10.1016/S1077-7229(98)80024-2 |
0.297 |
|
| 2013 |
Josiassen RC, Filmyer DM, Gillean JA, Shaughnessy RA. Vaptans are effective in treating hyponatremia in psychotic patients: but we need treatment guidelines. The Primary Care Companion For Cns Disorders. 15. PMID 24800120 DOI: 10.4088/Pcc.13Lr01575 |
0.297 |
|
| 1996 |
Tracy JI, de Leon J, Qureshi G, McCann EM, McGrory A, Josiassen RC. Repetitive behaviors in schizophrenia: a single disturbance or discrete symptoms? Schizophrenia Research. 20: 221-9. PMID 8794513 DOI: 10.1016/0920-9964(95)00104-2 |
0.297 |
|
| 1999 |
Simpson GM, Josiassen RC, Stanilla JK, de Leon J, Nair C, Abraham G, Odom-White A, Turner RM. Double-blind study of clozapine dose response in chronic schizophrenia. The American Journal of Psychiatry. 156: 1744-50. PMID 10553738 DOI: 10.1176/Ajp.156.11.1744 |
0.297 |
|
| 2003 |
Josiassen R, Joseph A, Kohegyi E, Paing W. Clozapine augmentation with risperidone in refractory schizophrenia Schizophrenia Research. 60: 288. DOI: 10.1016/S0920-9964(03)80474-7 |
0.296 |
|
| 2003 |
Watanabe TA, Cellucci CJ, Kohegyi E, Bashore TR, Josiassen RC, Greenbaun NN, Rapp PE. The algorithmic complexity of multichannel EEGs is sensitive to changes in behavior. Psychophysiology. 40: 77-97. PMID 12751806 DOI: 10.1111/1469-8986.00009 |
0.296 |
|
| 2012 |
Abraham WT, Decaux G, Josiassen RC, Yagil Y, Kopyt N, Thacker HP, Mannelli M, Bichet DG, Orlandi C. Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia. Kidney International. 82: 1215-22. PMID 22932122 DOI: 10.1038/Ki.2012.274 |
0.293 |
|
| 1980 |
Josiassen RC, Busk J, Hart AD, Vanderploeg R. Early auditory information processing in schizophrenia: a preliminary report. Biological Psychology. 10: 225-34. PMID 7470521 DOI: 10.1016/0301-0511(80)90018-6 |
0.292 |
|
| 2020 |
Harner MK, Lichtenstein M, Farrell M, Dietterich TE, Filmyer DM, Bruno LM, Biondi TF, Crowley JJ, Lázaro-Muñoz G, Stowe R, Shaughnessy RA, Berg JS, Szatkiewicz J, Sullivan PF, Josiassen RC. Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome. Schizophrenia Research. PMID 32943312 DOI: 10.1016/J.Schres.2020.08.012 |
0.289 |
|
| 2006 |
Jessani M, Montgomery J, Fedde JD, Josiassen RC. Lack of association between antipsychotics and hyponatremia in chronic schizophrenia. Schizophrenia Research. 83: 307-9. PMID 16504483 DOI: 10.1016/J.Schres.2005.12.859 |
0.288 |
|
| 1995 |
Tracy J, McGrory A, Josiassen R. Reading versus demographic-based estimates of premorbid intelligence in schizophrenia Biological Psychiatry. 37: 639-640. DOI: 10.1016/0006-3223(95)94578-K |
0.288 |
|
| 1998 |
Turner RM, Korslund KE, Barnett BE, Josiassen RC. Assessment of suicide in schizophrenia: Development of the interview for suicide in schizophrenia Cognitive and Behavioral Practice. 5: 139-169. DOI: 10.1016/S1077-7229(98)80002-3 |
0.288 |
|
| 2012 |
Abraham WT, Hensen J, Gross PA, Bichet DG, Josiassen RC, Chafekar DS, Orlandi C. Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia. Kidney International. 82: 1223-30. PMID 22932119 DOI: 10.1038/Ki.2012.275 |
0.288 |
|
| 2019 |
Farrell M, Lichtenstein M, Crowley J, Filmyer DM, Lazaro-Munoz G, Shaughnessy RA, Halvorsen M, Dietterich T, Bruno L, Harner M, Berg J, Szatkiewicz J, Josiassen RC, Sullivan P. S87GENETIC DIFFERENTIAL DIAGNOSIS IN ULTRA TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S158-S159. DOI: 10.1016/J.Euroneuro.2019.08.088 |
0.286 |
|
| 2007 |
de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Weight gain during a double-blind multidosage clozapine study. Journal of Clinical Psychopharmacology. 27: 22-7. PMID 17224708 DOI: 10.1097/Jcp.0B013E31802E513A |
0.282 |
|
| 1997 |
Verghese C, Levitan I, Nair C, Abraham G, Garber SS, Josiassen RC. Impaired lymphocyte volume regulation in schizophrenic patients with polydipsia-hyponatremia. Biological Psychiatry. 42: 733-6. PMID 9325567 DOI: 10.1016/S0006-3223(97)00259-X |
0.279 |
|
| 2005 |
Hahn CG, Gomez G, Restrepo D, Friedman E, Josiassen R, Pribitkin EA, Lowry LD, Gallop RJ, Rawson NE. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. The American Journal of Psychiatry. 162: 616-8. PMID 15741484 DOI: 10.1176/Appi.Ajp.162.3.616 |
0.279 |
|
| 1997 |
Tracy JI, Nematbakhsh MA, de Leon J, McCann EM, McGrory A, Quereshi G, Josiassen RC. A comparison of polydipsia prevalence among chronic psychiatric patients using three measurement approaches. Biological Psychiatry. 42: 1097-104. PMID 9426879 DOI: 10.1016/S0006-3223(97)00375-2 |
0.278 |
|
| 1994 |
White AO, Oesterling R, Tracy J, Cloud B, Leon Jd, Josiassen RC, Simpson G. Attentional effects on a test of ecological memory in schizophrenia Biological Psychiatry. 35: 634. DOI: 10.1016/0006-3223(94)90728-5 |
0.277 |
|
| 2004 |
de Leon J, Diaz FJ, Josiassen RC, Simpson GM. Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment. European Archives of Psychiatry and Clinical Neuroscience. 254: 318-25. PMID 15365707 DOI: 10.1007/S00406-004-0505-2 |
0.276 |
|
| 2003 |
Potkin SG, Alphs L, Hsu C, Krishnan KRR, Anand R, Young FK, Meltzer H, Green A, Altinsan S, Altman S, Avigo L, Balon R, Benešová V, Bengochea L, Bitter I, ... ... Josiassen RC, et al. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial Biological Psychiatry. 54: 444-452. DOI: 10.1016/S0006-3223(03)00178-1 |
0.276 |
|
| 2011 |
Josiassen RC, Curtis J, Filmyer DM, Geboy AG, Shaughnessy RA. 64-Year-Old Male with undifferentiated schizophrenia, lengthy institutionalization, water imbalance Psychiatric Annals. 41: 315-318. DOI: 10.3928/00485713-20110119-07 |
0.27 |
|
| 2003 |
Abraham G, Halbreich U, Friedman RH, Josiassen RC. Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophrenia Research. 59: 17-8. PMID 12413637 DOI: 10.1016/S0920-9964(01)00321-8 |
0.268 |
|
| 2020 |
Farrell M, Lichtenstein M, Harner MK, Crowley JJ, Filmyer DM, Lázaro-Muñoz G, Dietterich TE, Bruno LM, Shaughnessy RA, Biondi TF, Burkholder S, Donmoyer J, Berg JS, Szatkiewicz J, Sullivan PF, ... Josiassen RC, et al. Treatment-resistant psychotic symptoms and the 15q11.2 BP1-BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature. Translational Psychiatry. 10: 42. PMID 32066678 DOI: 10.1038/S41398-020-0725-X |
0.268 |
|
| 2017 |
Lázaro-Muñoz G, Farrell MS, Crowley JJ, Filmyer DM, Shaughnessy RA, Josiassen RC, Sullivan PF. Improved ethical guidance for the return of results from psychiatric genomics research. Molecular Psychiatry. PMID 29158581 DOI: 10.1038/Mp.2017.228 |
0.264 |
|
| 2014 |
Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan L, Fourches D, Huang H, Lek M, Neale BM, Ripke S, Shianna K, Szatkiewicz JP, Tropsha A, van den Oord EJ, Cascorbi I, ... ... Josiassen RC, et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nature Communications. 5: 4757. PMID 25187353 DOI: 10.1038/Ncomms5757 |
0.262 |
|
| 2011 |
Josiassen RC, Shaughnessy RA, Filmyer DM, Audino B. Attributing hyponatraemia to treatment with antipsychotic medications. Drug Safety. 34: 353-4; author reply . PMID 21417508 DOI: 10.2165/11589110-000000000-00000 |
0.261 |
|
| 2017 |
Lazaro-Munoz G, Farrell MS, Ward ET, Iglesias de Ussel MD, Filmyer DM, Finkel G, Crowley JJ, Shaughnessy RA, Josiassen RC, Juengst ET, Sullivan P. Framework For The Return of Results To Psychiatric Genomics Research Participants: What Should Be Offered? European Neuropsychopharmacology. 27: S371. DOI: 10.1016/J.Euroneuro.2016.09.399 |
0.259 |
|
| 2005 |
de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Does clozapine decrease smoking? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 757-62. PMID 15951089 DOI: 10.1016/J.Pnpbp.2005.04.031 |
0.258 |
|
| 2005 |
Diaz FJ, de Leon J, Josiassen RC, Cooper TB, Simpson GM. Plasma clozapine concentration coefficients of variation in a long-term study. Schizophrenia Research. 72: 131-5. PMID 15560958 DOI: 10.1016/J.Schres.2004.03.017 |
0.257 |
|
| 1994 |
De Leon J, Tracy J, McCann E, McGrory A, Josiassen R. Do polydipsia patients display other repetitive behaviors? Biological Psychiatry. 35: 698. DOI: 10.1016/0006-3223(94)90957-1 |
0.252 |
|
| 1996 |
Abraham G, Tracy J, Nair C, Josiassen R, Simpson G. The effects of clozapine on symptom clusters in older “treatment-refractory” patients Biological Psychiatry. 39: 543. DOI: 10.1016/0006-3223(96)84096-0 |
0.243 |
|
| 2018 |
Farrell M, Lichtenstein M, Crowley JJ, Filmyer DM, Lázaro-Muñoz G, Shaughnessy RA, Mackenzie IR, Hirsch-Reinshagen V, Stowe R, Evans JP, Berg JS, Szatkiewicz J, Josiassen RC, Sullivan PF. Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease. The American Journal of Psychiatry. 175: 400-407. PMID 29712475 DOI: 10.1176/Appi.Ajp.2017.17060638 |
0.24 |
|
| 2017 |
Josiassen R, Kane J, Burke J, Jimenez R, Siegert S, Liang G. M16. Valbenazine (NBI-98854) for the Treatment of Tardive Dyskinesia: Analysis by Underlying Psychiatric Diagnosis in Phase III KINECT 3 Study Schizophrenia Bulletin. 43: S217-S217. DOI: 10.1093/Schbul/Sbx022.015 |
0.236 |
|
| 2007 |
Diaz FJ, Rivera TE, Josiassen RC, de Leon J. Individualizing drug dosage by using a random intercept linear model. Statistics in Medicine. 26: 2052-73. PMID 16847902 DOI: 10.1002/Sim.2636 |
0.236 |
|
| 2018 |
Diaz FJ, Josiassen RC, de Leon J. The Effect of Body Weight Changes on Total Plasma Clozapine Concentrations Determined by Applying a Statistical Model to the Data From a Double-Blind Trial. Journal of Clinical Psychopharmacology. PMID 30106876 DOI: 10.1097/Jcp.0000000000000926 |
0.235 |
|
| 1997 |
Nair C, Abraham G, Stanilla JK, Simpson GM, Josiassen RC. Tardive dyskinesia and extrapyramidal symptoms in treatment-resistant schizophrenics treated with clozapine Schizophrenia Research. 24: 272. DOI: 10.1016/S0920-9964(97)82783-1 |
0.231 |
|
| 1995 |
Verghese C, de Leon J, Nair C, McGrory A, McCann E, Stanilla J, Josiassen R. Urine specific gravity may not measure polydipsia in the presence of water retention Schizophrenia Research. 15: 138. DOI: 10.1016/0920-9964(95)95429-D |
0.223 |
|
| 2012 |
Josiassen RC, Filmyer DM, Geboy AG, Martin D, Curtis JL, Shaughnessy RA. Impact of hyponatremia on resource utilization in state psychiatric hospitals: a retrospective analysis. Journal of Clinical Psychopharmacology. 32: 580-2; author reply . PMID 22760355 DOI: 10.1097/Jcp.0B013E31825E002A |
0.217 |
|
| 1997 |
Verghese C, Levitan I, Garber S, Nair C, Abraham G, Josiassen R. Cellular effects of serum osmolarity changes in polydipsia-hyponatremia Schizophrenia Research. 24: 69. DOI: 10.1016/S0920-9964(97)82192-5 |
0.217 |
|
| 2003 |
Abraham G, Paing WW, Kaminski J, Joseph A, Kohegyi E, Josiassen RC. Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study. The American Journal of Psychiatry. 160: 1618-20. PMID 12944336 DOI: 10.1176/Appi.Ajp.160.9.1618 |
0.216 |
|
| 2019 |
Filmyer DM, Finkel G, Plasay M, Shaughnessy RA, Josiassen RC. A comparison of simple reaction times in psychotic inpatients with and without hyponatremia. Schizophrenia Research. PMID 30992156 DOI: 10.1016/J.Schres.2019.04.001 |
0.215 |
|
| 2013 |
Josiassen RC, Filmyer DM, Geboy AG, Shaughnessy RA. Reconsidering chronic hyponatremia in psychosis. The Journal of Clinical Psychiatry. 74: 278-9. PMID 23561235 DOI: 10.4088/Jcp.12Ac08335 |
0.209 |
|
| 1995 |
de Leon J, Odom-White A, Stanilla J, Josiassen R, Simpson G. Does clozapine induce akathisia? Schizophrenia Research. 15: 206. DOI: 10.1016/0920-9964(95)95632-J |
0.196 |
|
| 2017 |
Josiassen RC, Kane JM, Liang GS, Burke J, O'Brien CF. Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder. Psychopharmacology Bulletin. 47: 61-68. PMID 28839341 |
0.186 |
|
| 1997 |
Cellucci CJ, Albano AM, Rapp PE, Pittenger RA, Josiassen RC. Detecting noise in a time series. Chaos (Woodbury, N.Y.). 7: 414-422. PMID 12779669 DOI: 10.1063/1.166214 |
0.183 |
|
| 2022 |
Farrell M, Dietterich TE, Harner MK, Bruno LM, Filmyer DM, Shaughnessy RA, Lichtenstein ML, Britt AM, Biondi TF, Crowley JJ, Lázaro-Muñoz G, Forsingdal AE, Nielsen J, Didriksen M, Berg JS, ... ... Josiassen RC, et al. Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis. Schizophrenia Bulletin. PMID 36454006 DOI: 10.1093/schbul/sbac175 |
0.181 |
|
| 2017 |
Correll CU, Josiassen RC, Liang GS, Burke J, O'Brien CF. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder. Psychopharmacology Bulletin. 47: 53-60. PMID 28839340 |
0.181 |
|
| 1997 |
Josiassen RC. End of the line Biological Psychiatry. 42: 1079. DOI: 10.1016/S0006-3223(97)00493-9 |
0.17 |
|
| 2003 |
Barnett B, Josiassen R. Risk factors for suicide in schizophrenia and schizoaffective disorder Schizophrenia Research. 60: 3-4. DOI: 10.1016/S0920-9964(03)80004-X |
0.16 |
|
| 2003 |
Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, Altinsan S, Altman S, ... ... Josiassen RC, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Archives of General Psychiatry. 60: 82-91. DOI: 10.1001/archpsyc.60.1.82 |
0.116 |
|
| 1993 |
Bridger WH, Josiassen RC, Bloom FE, Guze SB, Beckmann H. Letter from the editors Biological Psychiatry. 33: 2. DOI: 10.1016/0006-3223(93)90271-E |
0.062 |
|
| 1993 |
Bridger WH, Josiassen RC, Bloom FE, Guze SB, Beckmann H. Letter from the editors Biological Psychiatry. 33: 2. |
0.062 |
|
| 1980 |
Josiassen RC, Fantuzzo J, Rosen AC. Treatment of pedophilia using multistage aversion therapy and social skills training Journal of Behavior Therapy and Experimental Psychiatry. 11: 55-61. DOI: 10.1016/0005-7916(80)90054-3 |
0.038 |
|
| 1986 |
Josiassen RC, Simpson GM. Preface International Journal of Neuroscience. 31: v. DOI: 10.3109/00207458608985894 |
0.01 |
|
| Hide low-probability matches. |